Cipla | CIPLA - Cash And Equivalent

Stock Price
1,281.90
Daily Change
-18.10 -1.39%
Monthly
-5.03%
Yearly
-15.03%
Q1 Forecast
1,289.06

Cipla reported INR7.96B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Arca Biopharma USD 91.25M 25.86M Sep/2025
aTyr Pharma USD 6.15M 11.07M Sep/2025
Bio Path 13.65M 3.37M Sep/2022
Brainstorm Cell Therapeutics USD 5K 819K Sep/2025
Capricor Therapeutics USD 287.85M 268.34M Dec/2025
Cara Therapeutics USD 20.65M 13.57M Jun/2025
Cipla INR 7.96B 39.9M Sep/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Esperion Therapeutics USD 92.45M 6.39M Sep/2025
Immunic USD 35.13M 20.18M Sep/2025
Infinity Pharmaceuticals USD 17.75M 7.99M Jun/2023
Minerva Neurosciences USD 82.3M 70.02M Dec/2025
Nektar Therapeutics USD 41.03M 1.96M Sep/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
TherapeuticsMD 523K 89K Jun/2024
UPL INR 41.52B 53.85B Sep/2025